Insecticides (India) Earnings Call Transcript: Key Takeaways
Q2 revenue rose 8% to ₹686 Cr, but H1 fell 2%, volumes dropped 6-7% and Q2 PAT was ₹56 Cr. Management is upbeat yet hedges on margins, volume recovery and launch timelines.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Q2 revenue rose 8% to ₹686 Cr, but H1 fell 2%, volumes dropped 6-7% and Q2 PAT was ₹56 Cr. Management is upbeat yet hedges on margins, volume recovery and launch timelines.
Q2/H1 FY27 deck; no quarterly revenue, PAT or EBITDA disclosed. Highlights FY23–FY26 margin gains and H1 FY27 field-activity metrics.
Insecticides (India) released a press release on Q2 and H1 FY27 results. Revenue grew in Q2 while profit after tax declined over the half-year.
Insecticides (India) declared an interim dividend of Rs.5 per equity share on 5 November 2026 for 2026-2027. Record date is 12 November 2026 and payment is proposed by 17 November 2026.
Insecticides (India) Ltd reported revenue from operations of ₹686.3 Cr (+7.6% YoY) and net profit of ₹56.2 Cr (-4.9% YoY) for Q2 FY27.
Insecticides (India) will hold a board meeting on November 5, 2026 to consider an interim dividend for FY 2026-27. Record date is fixed as November 12, 2026.
Insecticides (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure.
CRISIL Ratings has reaffirmed the Long-Term and Short-Term credit ratings of Insecticides (India) Limited. There is no change in the ratings assigned to the company.
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.